Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Troy Ignelzi
EXECUTIVE ADVISOR, SOFINNOVA INVESTMENTS
From C-Suite to VC: Lessons from the Biotech Trenches
Montreal, Quebec, Canada
Troy Ignelzi
CHIEF FINANCIAL OFFICER, KARUNA THERAPEUTICS
In today’s disruptive health care environment, how will biotech transform?
Placeholder Photo
Hiroshi Ikeuchi, MBA
SR. MANAGER, GLOBAL BUSINESS DEVELOPMENT, OTSUKA PHARMACEUTICAL CO., LTD.
Otsuka Pharmaceutical Co., Ltd.
Princeton, New Jersey, United States
Kyung-Soo Inn, ACA
TRANSFORMING THE FUTURE OF TARGETED PROTEIN DEGRADATION (TPD) WITH SPIDEM, PRAZER THERAPEUTICS
Prazer Therapeutics
Seoul, Republic of Korea
Kelly Irwin
DIRECTOR OF THE COLLABORATIVE CARE AND COMMUNITY ENGAGEMENT PROGRAM, MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER
The Intersection of Cancer and Mental Health: Improving Equity and Access to Quality Care
Boston, Massachusetts, United States
Cynthia Isaac
MANAGING DIRECTOR, SYNEOS HEALTH
Y-Not: Are There Leadership Advantages Women Bring to the Biopharma C-Suite?
Women at the Crossroads in Gene Editing
Christina Isacson, PhD
PARTNER, LIGHTSTONE VENTURES
Why Health Systems Are Funding the Commercialization of New Therapies: A New Player in Biotech Investing
Josh Israel
CBRN FUTURES, JPEO CBRND HEADQUARTERS DIRECTOR, JPEO-CBRND
Sustainable Innovation: Addressing 21st Century Health Security Threats (DoD/ASPR Engagement Day)
Vijay Iyengar, MD
EXECUTIVE VICE PRESIDENT, GLOBAL MEDICAL AFFAIRS, PRODUCT, AND PARTNERSHIP STRATEGY, INCYTE
Expanding Beyond Borders: The Role of Business Development Deals in Building a Global Biotech